EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Unveiling Therapeutic Targets for Esophageal Cancer: A Comprehensive Review

Rakesh Acharya iD, Ananya Mahapatra iD, Henu Kumar Verma iD, L V K S Bhaskar iD

Current Oncology · 2023

DOI: 10.3390/curroncol30110691 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Oncology, 2023. Verfasst von Rakesh Acharya und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Zoology, Guru Ghasidas Vishwavidyalaya, Bilaspur 495009, India. Hauptthemen laut MEDLINE: Esophageal Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 161 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Esophageal cancer is a highly aggressive and deadly disease, ranking as the sixth leading cause of cancer-related deaths worldwide. Despite advances in treatment, the prognosis remains poor. A multidisciplinary approach is crucial for achieving complete remission, with treatment options varying based on disease stage. Surgical intervention and endoscopic treatment are used for localized cancer, while systemic treatments like chemoradiotherapy and targeted drug therapy play a crucial role. Molecular markers such as HER2 and EGFR can be targeted with drugs like trastuzumab and cetuximab, and immunotherapy drugs like pembrolizumab and nivolumab show promise by targeting immune checkpoint proteins. Epigenetic modifications offer new avenues for targeted therapy. Treatment selection depends on factors like stage, tumor location, and patient health, with post-operative and rehabilitation care being essential. Early diagnosis, appropriate treatment, and supportive care are key to improving outcomes. Continued research is needed to develop effective targeted drugs with minimal side effects. This review serves as a valuable resource for clinicians and researchers dedicated to enhancing esophageal cancer treatment outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophageal NeoplasmsHumansCetuximabNivolumabImmunotherapyTreatment Outcome

Stichwörter der Autor:innen

esophageal cancermolecular markersmultidisciplinary approachprognosistargeted therapy

Substanzen

CetuximabNivolumab

Autor:innen und Institutionen

  • Department of Zoology, Guru Ghasidas Vishwavidyalaya, Bilaspur 495009, India.
  • Department of Immunopathology, Institute of lungs Health and Immunity, Comprehensive Pneumology Center, Helmholtz Zentrum, Neuherberg, 85764 Munich, Germany.

ORCID-Profile: Rakesh Acharya, Ananya Mahapatra, Henu Kumar Verma, L V K S Bhaskar

Zitieren

APA

Acharya, R., Mahapatra, A., Verma, H. K., & Bhaskar, L. V. K. S. (2023). Unveiling Therapeutic Targets for Esophageal Cancer: A Comprehensive Review. Current Oncology. https://doi.org/10.3390/curroncol30110691

Vancouver

Acharya R, Mahapatra A, Verma HK, Bhaskar LVKS. Unveiling Therapeutic Targets for Esophageal Cancer: A Comprehensive Review. Current Oncology. 2023. doi:10.3390/curroncol30110691

BibTeX
@article{Acharya2023,
  author = {Acharya, Rakesh and Mahapatra, Ananya and Verma, Henu Kumar and Bhaskar, L V K S},
  title = {Unveiling Therapeutic Targets for Esophageal Cancer: A Comprehensive Review},
  journal = {Current Oncology},
  year = {2023},
  doi = {10.3390/curroncol30110691}
}
Kostenlos starten →